宫颈癌术前介入治疗的临床效果分析

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (37 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the clinical value of uterine arterial chemoembolization in the treatment of cervical carcinoma.Methods Thirty patients with cervical cancer of stageⅡa-Ⅱb treated in our hospital from March 2014 to August 2016 were selected as the study group,who underwent radical hysterectomy followed by uterine arterial chemoembolization.Thirty patients who underwent radical resection of cervical cancer at the same period were selected as the control group.The short-term efficacy,tumor shrinkage,the volume of intraoperative blood loss,operation time and postoperative pathological results were analyzed.Results After interventional treatment,the clinical symptoms of patients were relieved in different degrees,the remission rate was 100%,and the total effective rate of short-term curative effect for interventional therapy was 76.67%.There was no significant difference in the effective rate of intervention between study group at stageⅡa andⅡb (P＞0.05).The tumor diameter in the study group after interventional treatment was lower than before intervention,and the difference was statistically significant (P＜0.05).The volume of intraoperative blood loss in the study group was less than that in the control group,and the rate of cancer metastasis of lymph node,vascular tumor thrombus and para uterine infiltration after operation were all lower than those in the control group,and the difference was statistically significant(P＜0.05).ConclusionInterventional therapy before radical resection of cervical cancer can effectively reduce the size of tumor,the short-term curative effect is obvious,and can improve the clinical symptoms of patients,effectively inhibit the cancer metastasis of lymph node,vascular tumor thrombus,and para uterine invasion,and reduce the risk of operation.

Key words： Cervical carcinoma Neoadjuvant chemotherapy Chemoembolization of uterine artery Interventional therapy

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	DING Lin-Kang
	LIU Bing-Yuan
	JIANG Li-Ping

Cite this article:

DING Lin-Kang,LIU Bing-Yuan,JIANG Li-Ping. Clinical effect analysis of preoperative interventional therapy for cervical cancer[J]. 中国当代医药, 2018, 25(9): 16-19.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2018/V25/I9/16

[1]	Jemal A，Bray F，Center MM，et al.Global cancer statistics[J].CA Cancer J Clin，2011，61（2）： 69-90.
[2]	褚丹霞，郭瑞霞，褚艳丽，等.不同治疗方式对宫颈癌患者卵巢功能的影响[J].河南医学研究，2017，26（22）：1-3.
[3]	贺斌，谭隆旺，孙寒，等.介入化疗栓塞在宫颈癌手术治疗中的应用[J].昆明医学院学报，2012，33（3）：96-99，103.
[4]	Frei E 3rd.Clinical cancer research：an embattled species[J].Cancer，1982，50（10）：1979-1992.
[5]	Kobayashi K，Furukawa A，Takahashi M，et al.Neoadjuvant intra-arterial chemotherapy for locally advanced uterine cervical cancer：clinical efficacy and factors influencing response[J].Cardiovasc Intervent Radiol，2003，26（3）：234-241.
[6]	Lorusso D，Ramondino S，Mancini M，et al.Phase Ⅱ trial oncisplatin-adriamycin-paclitaxel combination as neoadjuvant chemotherapy for locally advanced cervical adenocarcinoma[J].Int J Gynecol Cancer，2014，24（4）：729-734.
[7]	廖万清，汤新跃.廖万清，等.术前新辅助化疗在局部晚期宫颈癌治疗中的临床价值[J].实用癌症杂志，2015，30（2）：266-268.
[8]	李斯锐，吴宁，杨进全，等.盆腔肿瘤供血及介入治疗选择[J].海南医学，2001，12（1）：12-13.
[9]	马秋英.宫颈癌手术前治疗[J].华夏医学，2007，20（5）：1145-1148.
[11]	范振华，刘福全，岳振东，等.介入治疗中晚期宫颈癌38例近期临床疗效分析[J].中国临床医生杂志，2016，44（6）：74-76.
[12]	刘萍，陈春林，曾北蓝，等.宫颈癌术前动脉化疗的组织病理学动态变化及临床结局[J].中国实用妇科与产科杂志，2006，22（2）：109-111.
[10]	Chhetri G，Ghosh A，Chinta R，et al.Cloning，soluble expression，andpurificationoftheRNApolymeraseⅡsubunitRPB5 from Saccharomyces cerevisiae[J].Bioengineered，2014，11（31）：1-5.
[13]	叶元，尹茳平，李力，等.影响宫颈癌手术疗效临床病理因素的循证评价[J].广西医学，2011，33（10）：1262-1266.
[14]	Bae JH，Lee SJ，Lee A，et al.Neoadjuvant cisplatin and etoposide followed by radical hysterectomy for stage 1B-2B cervical cancer[J].Gynecol Oncol，2008，111（3）：444-844.
[15]	蔡丽萍，易为民，刘丝荪，等.中晚期宫颈癌血管介入治疗 61 例应用[J].肿瘤学杂志，2004，10（2）：78-81.